CHD1Li 6.11
CHD1Li 6.11 is a potent inhibitor of oncogenic CHD1L, acting on the cat-CHD1L recombinant protein (IC50: 3.3 μM) . CHD1Li 6.11 is an orally active antitumour agent that significantly reduces the tumour volume of CRC xenografts generated from isolated quasi-mesenchymal cells (M phenotype) with enhanced tumourigenic properties. These cells have enhanced tumourigenic properties.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
472.4
Molecular Formula
C21H22BrN5OS
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
2716890-91-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
